Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.56 |
| ▸ | CA2 | P00918 | 6/20 | 0.56 |
| ▸ | CA12 | O43570 | 4/20 | 0.56 |
| ▸ | CA7 | P43166 | 4/20 | 0.56 |
| ▸ | CA9 | Q16790 | 4/20 | 0.56 |
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.56 |
| ▸ | ESR1 | P03372 | 5/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 3/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 1/20 | 0.48 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.47 |
| ▸ | KDR | P35968 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2402587 | 0.91 | ALDH1A1 (0.46) | CA1CA2CA12CA7CA9 | |
| SCHEMBL22191623 | 0.82 | TSHR (0.55) | CA1CA2CA12CA7CA9 | |
| SCHEMBL9330930 | 0.81 | KMT2A (0.50) | ESR1ESR2MEN1KMT2ATSHR | |
| SCHEMBL9630702 | 0.80 | CES2 (0.50) | CA1CA2MEN1KMT2AMAPT | |
| SCHEMBL15846817 | 0.80 | LMNA (0.52) | MEN1KMT2ALMNAMAPTPKM | |
| SCHEMBL1377357 | 0.80 | CES2 (0.50) | CA1CA2MEN1KMT2ALMNA | |
| SCHEMBL9364286 | 0.80 | CES2 (0.50) | CA1CA2ESR1ESR2MEN1 | |
| SCHEMBL10050028 | 0.80 | TDP1 (0.59) | MEN1KMT2ALMNAMAPTPKM | |
| SCHEMBL689989 | 0.80 | CA1 (0.54) | CA1CA2CA12CA7CA9 | |
| SCHEMBL28748274 | 0.80 | CA1 (0.59) | CA1CA2CA12CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119280201-A | Application of formylparanol mixed source terpenoid derivatives or pharmaceutically acceptable salts thereof in preparation of medicines for preventing and treating liver lipid metabolism abnormality related diseases | 中国药科大学 | 2025-01-10 | — | — | CN | claimed |
| CN-104945449-B | Bioactive ingredients and its medical usage in Green Bamboo Leaf Liquor | 石河子大学 | 2017-10-24 | — | — | CN | claimed |
| US-8114775-B2 | Dihydroxy enol compounds used in chemical mechanical polishing compositions having metal ion oxidizers | DUPONT AIR PRODUCTS NANOMATERIALS, LLC (US) | 2012-02-14 | — | — | US | claimed |
| EP-1871855-B1 | DIHYDROXY ENOL COMPOUNDS USED IN CHEMICAL MECHANICAL POLISHING COMPOSITIONS HAVING METAL ION OXIDIZERS | DUPONT AIR PROD NANOMATERIALS (US) | 2010-03-24 | — | — | EP | claimed |
| US-20090308836-A1 | DIHYDROXY ENOL COMPOUNDS USED IN CHEMICAL MECHANICAL POLISHING COMPOSITIONS HAVING METAL ION OXIDIZERS | VERSUM MATERIALS US, LLC | 2009-12-17 | — | — | US | claimed |
| EP-1871855-A1 | DIHYDROXY ENOL COMPOUNDS USED IN CHEMICAL MECHANICAL POLISHING COMPOSITIONS HAVING METAL ION OXIDIZERS | DuPont Air Products NanoMaterials L.L.C. (US) | 2008-01-02 | — | — | EP | claimed |
| US-20060270235-A1 | Dihydroxy enol compounds used in chemical mechanical polishing compositions having metal ion oxidizers | VERSUM MATERIALS US, LLC | 2006-11-30 | — | — | US | claimed |
| WO-2006105020-A1 | DIHYDROXY ENOL COMPOUNDS USED IN CHEMICAL MECHANICAL POLISHING COMPOSITIONS HAVING METAL ION OXIDIZERS | DUPONT AIR PRODUCTS NANOMATERIALS LLC (US) | 2006-10-05 | — | — | WO | claimed |
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | CAVALIER DISCOVERY | 2003-05-01 | — | — | US | claimed |
| WO-2002100478-A9 | ACCELERATORS FOR INCREASING THE RATE OF FORMATION OF FREE RADICALS AND REACTIVE OXYGEN SPECIES | CAVALIER DISCOVERY (US) | 2003-03-27 | — | — | WO | claimed |
| US-5621006-A | TOPICALLY APPLYING IN A VEHICLE, E.G. HYDROXYACIDS, KETOACIDS AND SALTS, ESTERS THEREOF | YU RUEY J (US) | 1997-04-15 | — | — | US | claimed |
| EP-0599819-B1 | Use of hydroxycarboxylic acids and derivatives for the preparation of topical dermatologic compositions for the treatment of wrinkles | SCOTT EUGENE J VAN (US) | 1997-04-02 | — | — | EP | claimed |
| US-5561157-A | INCLUDES ORGANIC ALPHA AND BETA HYDROXY OR KETO CARBOXYLIC ACIDS, ESTERS, LACTONES AND/OR SALTS; USED FOR SKIN DISORDERS | TRISTRATA INC (US) | 1996-10-01 | — | — | US | claimed |
| US-5561158-A | Compositions comprising 2-hydroxycarboxylic acids and related compounds, and methods for alleviating signs of dermatological aging | TRISTRATA, INCORPORATED | 1996-10-01 | — | — | US | claimed |
| US-5554654-A | COMPRISING SALICYLIC ACID, RETINOIC ACID, ERYTHROMYCIN, METRONIDAZOLE, TETRACYCLINE, CLINDAMYCIN, MINOCYCLINE, MECLOCYCLINE OR BENZILIC ACID BY COMBINING WITH 2-HYDROXY ACID, 2-KETOACID, DERIVATIVE THEREOF OR RELATED COMPOUND | TRISTRATA INC (US) | 1996-09-10 | — | — | US | claimed |
| US-5554652-A | TOPICALLY APPLYING MIXTURE TO REDUCE OR PREVENT SKIN DISORDERS | TRISTRATA INC (US) | 1996-09-10 | — | — | US | claimed |
| EP-0273202-B1 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | SCOTT EUGENE J VAN (US) | 1995-06-21 | — | — | EP | claimed |
| EP-0599819-A2 | Additives enhancing topical actions of therapeutic agents | Van Scott, Eugene J., Dr. (US) | 1994-06-01 | — | — | EP | claimed |
| CN-1031648-A | Prevent mean that elastomeric material is made and manufacture method thereof | HUTCHINSON (FR) | 1989-03-15 | — | — | CN | claimed |
| EP-0273202-A2 | Use of hydroxycarboxylic acids to enhance therapeutic effects of topical compositions for fungal infections and pigmented spots. | Van Scott, Eugene J., Dr. (US) | 1988-07-06 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030082101-A1 | Accelerators for increasing the rate of formation of free radicals and reactive oxygen species | SOD1, SOD3, APEX1 | CA1 1349/4885CA2 493/4885CA12 1542/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.